An update of combined modality therapy for patients with muscle invading bladder cancer using selective bladder preservation or cystectomy

Journal of Urology

Volumn 162, Issue 2, 1999, Pages 445-450

  Shipley, William U ^a   Kaufman, Donald S ^a   Heney, Niall M ^a   Althausen, Alex F ^a   Zietman, Anthony L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bladder; Cystectomy; Neoplasm invasiveness

Indexed keywords

CISPLATIN; METHOTREXATE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; BLADDER CANCER; CANCER CLASSIFICATION; CANCER SURVIVAL; CONFERENCE PAPER; CYSTECTOMY; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; MULTIMODALITY CANCER THERAPY; OUTCOMES RESEARCH; PRIORITY JOURNAL; SURVIVAL RATE; TRANSURETHRAL RESECTION;

EID: 0032883705     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68582-5     Document Type: Conference Paper

References (52)

1. Gospodarowicz, M. K., Quilty, P. M., Scalliet, P., Tsujii, H., Fossa, S. D., Horenblas, S., Isaka, S., Prout, G. R., Shipley, W. U., Wijnmaalen, A. J., Crawford, E. D., Jones, W. G. and Kawai, T.: The place of radiation therapy as definitive treatment of bladder cancer. Int. J. Urol., suppl., 2: 41, 1995.
2. Zietman, A. L., Shipley, W. U. and Kaufman, D. S.: The combination of cisplatinum based chemotherapy and radiation in the treatment of muscle-invading transitional cell cancer of the bladder. Int. J. Rad. Oncol. Biol. Phys., 27: 161, 1993.
3. Javle, M. and Raghavan, D.: Systemic therapy for invasive bladder cancer. Cancer Control, 3: 501, 1996.
4. Jung, P. and Jaske, G.: Bladder preservation in invasive locally confined bladder cancer. Onkologie, 19: 296, 1996.
5. Geven, K. M., Spera, J. A., Solin, L. J., Morgan, T. and Hanks, G. E.: Local control after cystectomy alone in bladder carcinoma. Cancer, 69: 2767, 1992.
6. Martinez-Pineiro, J. A., Gonzalez Martin, M., Arocena, N. F., Flores, N., Roncero, C. R., Portillo, J. A., Escudero, A., Jimenez Cruz, F. and Isorna, S.: Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: a prospective randomized phase III study. J. Urol., 153: 964, 1995.
7. Pressler, L. B., Petrylak, D. P. and Olsson, C. A.: Invasive transitional cell carcinoma of the bladder: prognosis and management. In: Urologic Oncology. Edited by J. E. Osterling and J. P. Richie. Philadelphia: W. B. Saunders Co., pp. 275-291, 1997.
8. Miller, L. S.: Bladder cancer: superiority of preoperative radiation in cystectomy in clinical stage T3. Cancer, 39: 973, 1977.
9. Horwich, A., Pendlebury, S. and Dearnaley, D. P.: Organ conservation in bladder cancer. Eur. J. Cancer, suppl., 31: 208, 1995.
10. Sell, A., Jakobsen, A. and Nerstrom, B.: Treatment of advanced bladder cancer category T2, T3, T4a. Scand. J. Urol. Nephrol., suppl., 138: 193, 1991.
11. Schultz, P. K., Herr, H. W., Zhang, Z. F., Bajorin, D. F., Seidman, A., Sarkis, A., Fair, W. R., Scherr, D., Bosl, G. J. and Scher, H. I.: Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival in patients treated with M-VAC with 5-year follow-up. J. Clin. Oncol., 12: 1394, 1994.
12. Herr, H. W.: Conservative management of muscle-infiltrating bladder cancer: prospective experience. J. Urol., 138: 1162, 1987.
13. Henry, K., Miller, J., Mort, M., Loening, S. and Fallon, B.: Comparison of transurethral resection to radical therapies for stage B bladder tumors. J. Urol., 140: 964, 1988.
14. DeNeve, W., Lybeert, M. L. and Goor, C.: Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time. Rad. Oncol., 36: 183, 1995.
15. Gospodarowicz, M. K., Hawkins, N. V., Rawlings, G. A., Connolly, J. G., Jewett, M. A. S., Thomas, G. M., Herman, J. G., Garrett, P. G., Chua, T., Duncan, W., Buckspan, M., Sugar, L. and Rider, W. D.: Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. J. Urol., 142: 1448, 1989.
16. Jenkins, B. J., Caulfield, M. J., Fowler, C. G., Badenoch, D. F., Tiptaft, R. C., Paris, A. M., Hope-Stone, H. F., Oliver, R. T. and Blandy, J. P.: Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive bladder cancer. Brit. J. Urol., 62: 343, 1988.
17. Mameghan, H., Fisher, R., Mameghan, J. and Brook, S.: Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder. Int. J. Rad. Oncol. Biol. Phys., 31: 247, 1995.
18. Shearer, R. J., Chilvers, C. F., Bloom, H. J. G., Bliss, J. M., Horwich, A. and Babiker, A.: Adjuvant chemotherapy in T3 carcinoma of the bladder. Brit. J. Urol., 62: 558, 1988.
19. Hall, R. R.: Transurethral resection for transitional cell carcinoma. Prob. Urol., 6: 460, 1992.
20. Quilty, P. and Duncan, W.: Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control. Int. J. Rad. Oncol. Biol. Phys., 12: 853, 1986.
21. Smaaland, R., Akslen, L. A., Tonder, B., Mehus, A., Lote, K. and Albrektsen, G.: Radical radiation treatment of invasive and locally advanced bladder carcinoma in elderly patients. Brit. J. Urol., 67: 61, 1991.
22. Farah, R., Chodak, G. W., Vogelzang, N. J., Awan, A. M., Quiet, C. A., Moormeier, J., Schoenberg, M. and Weichselbaum, R. R.: Curative radiotherapy following chemotherapy for invasive bladder carcinoma (a preliminary report). Int. J. Rad. Oncol. Biol. Phys., 20: 413, 1991.
23. Hall, R. R. and Roberts, J. T.: Neoadjuvant chemotherapy, a method to conserve the bladder? Eur. J. Cancer, suppl. 2, 27: S29, 1991.
24. Keating, J. P., Zincke, H., Morgan, W. R. and Hahn, R. G.: Extended experience with neoadjuvant (M-VAC) chemotherapy for invasive transitional cell carcinoma (TCC) of the urinary bladder. J. Urol., 141: 244A, abstract 298, 1989.
25. Kurth, K. I. I., Splinter, T. A. and Jacqmin, D.: Transitional cell carcinoma of the bladder: a phase II study of chemotherapy in T3-4 NO MO of the EORTC GU group. In: Urological Oncology Dilemmas and Developments. Edited by A. R. Alderson, R. T. Oliver, I. W. Hanham and H. J. Bloom. New York: Wiley-Liss, pp. 115-128, 1991.
26. Maffezzini, M., Torelli, T., Villa, E., Corrada, P., Bolognesi, A., Leidi, G. L., Rigatti, P. and Campo, B.: Systemic preoperative chemotherapy with cisplatin, methotrexate and vinblastine for locally advanced bladder cancer: local tumor response and early followup results. J. Urol., 145: 741, 1991.
27. Roberts, J. T., Fossa, S. D., Richards, B., Kaye, S. B., White, E. F., Robinson, M. C., Uscinska, B. and Parmar, M. K.: Results of Medical Research Council phase II study of low dose cisplatin and methotrexate in the primary treatment of locally advanced (T3 and T4) transitional cell carcinoma of the bladder. Brit. J. Urol., 68: 162, 1991.
28. Hall, R. R., Newling, D. W., Ramsden, P. D., Richards, B., Robinson, M. R. and Smith, P. M.: Treatment of invasive bladder cancer by local resection and high dose methotrexate. Brit. J. Urol., 56: 668, 1984.
29. Parsons, J. T. and Million, R. R.: Bladder cancer. In: Principles and Practice of Radiation Oncology. Edited by C. A. Perez and I. W. Brady. Philadelphia: Lippincott, pp. 1036-1058, 1991.
30. Prout, G. R., Jr., Shipley, W. U., Kaufman, D. S., Heney, N. M., Griffin, P. P., Althausen, A. F., Bassil, B., Nocks, B. N., Parkhurst, E. C. and Young, H. H., II: Preliminary results in invasive bladder cancer with transurethral resection, neoadjuvant chemotherapy and combined pelvic irradiation plus cisplatin chemotherapy. J. Urol., 144: 1128, 1990.
31. Scher, H. I., Herr, H. W. and Sternberg, C.: Neoadjuvant chemotherapy for invasive bladder cancer. Experience with the MVAC regimen. Brit. J. Urol., 64: 250, 1989.
32. Fung, C. Y., Shipley, W. U., Young, R. H., Griffin, P. P., Convery, K. M., Kaufman, D. S., Althausen, A. F., Heney, N. M. and Prout, G. R., Jr.: Prognostic factors in invasive bladder carcinoma in a prospective trial of neoadjuvant chemotherapy and radiotherapy. J. Clin. Oncol., 9: 1533, 1991.
33. Cervak, J., Cufer, T. and Marolt, F.: Combined chemotherapy and radiotherapy in muscle-invasive bladder carcinoma. Complete remission results. Eur. J. Cancer Clin. Oncol., 6: abstract 561, 1991.
34. Dunst, J., Sauer, R., Schrott, K. M., Kuhn, R., Wittekind, C. and Altendorf-Hofmann, A.: An organ-sparing treatment of advanced bladder cancer: a 10-year experience. Int. J. Rad. Oncol. Biol. Phys., 30: 261, 1994.
35. Tester, W., Porter, A., Asbell, S., Coughlin, C., Heaney, J., Krall, J., Marty, K., Venner, P. and Hammond, E.: Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12. Int. J. Rad. Oncol. Biol. Phys., 25: 783, 1993.
36. Shipley, W. U., Zietman, A. L., Kaufman, D. S., Althausen, A. F. and Heney, N. M.: Invasive bladder cancer: treatment strategies using transurethral surgery, chemotherapy and radiation therapy with selection for bladder conservation. Int. J. Rad. One. Biol. Phy., 39: 937, 1997.
37. Tester, W., Caplan, R., Heaney, J., Venner, P., Whittington, R., Byhardt, R., True, L. and Shipley, W.: Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802. J. Clin. Oncol., 14: 119, 1996.
38. Kachnic, L. A., Kaufman, D. S., Griffin, P. P., Heney, N. M., Althausen, A. F., Zietman, A. L. and Shipley, W. U.: Bladder preservation by combined modality therapy for invasive bladder cancer. J. Clin. Oncol., 15: 1022, 1997.
39. Shipley, W. U., Winter, K. A., Kaufman, D. S., Lee, W. R., Heney, N. M., Tester, W. R., Donnelly, B. J., Venner, P. M., Perez, C. A., Murray, K. J., Doggett, R. S. and True, L. D.: Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J. Clin. Oncol., 16: 3576, 1998.
40. Given, R. W., Parsons, J. T., McCarley, D. and Wajsman, Z.: Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: a five-year follow-up. Urology, 46: 499, 1995.
41. Srougi, M. and Simon, S. D.: Primary methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy in bladder preservation in locally invasive bladder cancer: a 5-year followup. J. Urol., 151: 593, 1994.
42. Sternberg, C. N., Raghaven, D., Ohi, Y., Bajorin, D., Herr, H., Kato, T., Kuroda, M., Logothetis, C. M., Scher, M. and Splinter, T. A.: Neoadjuvant and adjuvant chemotherapy in advanced disease - what are the effects on survival and prognosis? Int. J. Urol., suppl., 2: 76, 1995.
43. Houssett, M., Dufour, E. and Maulard-Durtux, C.: Concomitant 5-Fluouracil cisplatin and bifractionated split course radiation therapy for invasive bladder cancer. Proc. Amer. Soc. Clin. Oncol., 16: 319, abstract 1139, 1997.
44. Housset, M., Maulard, C., Chretien, Y. C., Dufour, B., Delanian, S., Huart, J., Colardelle, F., Brunel, P. and Baillet, F.: Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study. J. Clin. Oncol., 11: 2150, 1993.
45. Sauer, R., Birkenhake, S., Kuhn, R., Wittekind, C., Schrott, K. M. and Martus, P.: Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int. J. Rad. Oncol. Biol. Phys., 40: 121, 1998.
46. Herr, H. W., Bajorian, D. F., Scher, H. I.: Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: 10 year outcome. J. Clin. Oncol., 16: 1298, 1998.
47. Shipley, W. U., Zietman, A. L., Kaufman, D. S., Althausen, A. F., Heney, N. M. and Lane, S. C.: Long term success of selective bladder preservation by combined modality therapy for muscle invading bladder cancer. Radiother. Oncol., suppl., 48: abstract 261, 1998.
48. Batterman, J. J. and Tierie, A. H.: Results of implantation for T1 and T2 bladder tumors. Radiother. Oncol., 5: 85, 1986.
49. Mazeron, J., Crook, J., Chopin, D., Abbou, C. C., Le Bourgeois, J. P., Auvert, J. and Pierquin, B.: Conservative treatment of bladder carcinoma by partial cystectomy and interstitial indium 192. Int. J. Rad. Oncol. Biol. Phys., 15: 1323, 1988.
50. DeNeve, W., Lybeert, M. L. M. and Goo, C.: T1 and T2 carcinoma of the urinary bladder: long term results with external, preoperative or interstitial radiotherapy. Int. J. Rad. Oncol. Biol. Phys., 23: 299, 1992.
51. Rozan, R., Albuisson, E., Donnarieix, D., Giraud, B., Mazeron, J. J., Gerard, J. P., Pernot, M., Gerbaulet, A., Baillet, F. and Douchez, J.: Interstitial iridium-192 for bladder cancer (a multicentric survey: 205 patients). Int. J. Rad. Oncol. Biol. Phys., 24: 469, 1992.
52. Wijnmaalen, A., Helle, P. A., Koper, P. C., Jansen, P. P., Hanssens, P. E., Boeken Kruger, C. G. and van Putten, W. L.: Muscle invading bladder cancer treated by transurethral resection followed by external beam radiation and interstitial irridium-192. Int. J. Rad. Oncol. Biol. Phys., 39: 1043, 1997.